BioInvent International AB - ESG Rating & Company Profile powered by AI
Complete ESG analysis of BioInvent International AB can be accessed by signing in. Browse to the bottom of the page for potential risks for BioInvent International AB based on industry, geography and marketcap. This webpage includes a questions and answers section on BioInvent International AB.
BioInvent International AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 2.0, social score of 8.0 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | BioInvent International AB | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does BioInvent International AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes BioInvent International AB disclose current and historical energy intensity?
Sign up for free to unlockDoes BioInvent International AB report the average age of the workforce?
Sign up for free to unlockDoes BioInvent International AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes BioInvent International AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes BioInvent International AB disclose cybersecurity risks?
Sign up for free to unlockDoes BioInvent International AB offer flexible work?
Sign up for free to unlockDoes BioInvent International AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes BioInvent International AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes BioInvent International AB conduct supply chain audits?
Sign up for free to unlockDoes BioInvent International AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes BioInvent International AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes BioInvent International AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes BioInvent International AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes BioInvent International AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes BioInvent International AB disclose water use targets?
Sign up for free to unlockDoes BioInvent International AB have careers partnerships with academic institutions?
Sign up for free to unlockDid BioInvent International AB have a product recall in the last two years?
Sign up for free to unlockDoes BioInvent International AB disclose incidents of discrimination?
Sign up for free to unlockDoes BioInvent International AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas BioInvent International AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes BioInvent International AB disclose parental leave metrics?
Sign up for free to unlockDoes BioInvent International AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes BioInvent International AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes BioInvent International AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes BioInvent International AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes BioInvent International AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes BioInvent International AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs BioInvent International AB involved in embryonic stem cell research?
Sign up for free to unlockDoes BioInvent International AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes BioInvent International AB disclose its waste policy?
Sign up for free to unlockDoes BioInvent International AB report according to TCFD requirements?
Sign up for free to unlockDoes BioInvent International AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes BioInvent International AB disclose energy use targets?
Sign up for free to unlockDoes BioInvent International AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes BioInvent International AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for BioInvent International AB
These potential risks are based on the size, segment and geographies of the company.
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.